Geode Capital Management LLC Purchases 5,921 Shares of Inogen, Inc. (NASDAQ:INGN)

Geode Capital Management LLC boosted its position in Inogen, Inc. (NASDAQ:INGN) by 1.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 554,191 shares of the medical technology company’s stock after acquiring an additional 5,921 shares during the period. Geode Capital Management LLC owned 2.33% of Inogen worth $5,377,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in INGN. Divisadero Street Capital Management LP increased its stake in Inogen by 682.3% during the 2nd quarter. Divisadero Street Capital Management LP now owns 2,346,766 shares of the medical technology company’s stock valued at $19,079,000 after purchasing an additional 2,046,766 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. raised its holdings in shares of Inogen by 312.5% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 174,625 shares of the medical technology company’s stock worth $1,694,000 after acquiring an additional 132,287 shares during the last quarter. AQR Capital Management LLC lifted its position in Inogen by 29.3% in the 2nd quarter. AQR Capital Management LLC now owns 570,994 shares of the medical technology company’s stock valued at $4,642,000 after acquiring an additional 129,307 shares in the last quarter. Sanctuary Advisors LLC acquired a new position in Inogen during the 2nd quarter valued at about $651,000. Finally, Monaco Asset Management SAM purchased a new stake in shares of Inogen in the second quarter worth approximately $610,000. Institutional investors and hedge funds own 89.94% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently commented on the company. StockNews.com lowered Inogen from a “buy” rating to a “hold” rating in a research report on Friday, December 20th. Needham & Company LLC reiterated a “hold” rating on shares of Inogen in a report on Friday, November 8th.

Inogen Stock Up 4.7 %

INGN opened at $9.62 on Friday. The company has a market capitalization of $229.13 million, a price-to-earnings ratio of -4.28 and a beta of 1.02. The firm has a 50-day moving average price of $9.39 and a 200-day moving average price of $9.77. Inogen, Inc. has a twelve month low of $5.08 and a twelve month high of $13.33.

Inogen Profile

Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.